Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
Wang S, Chan KW, Wei D, Ma X, Liu S, Hu G, Park S, Pan R, Gu Y, Nazzari AF, Olia AS, Xu K, Lin BC, Louder MK, McKee K, Doria-Rose NA, Montefiori D, Seaman MS, Zhou T, Kwong PD, Arthos J, Kong XP, Lu S.
Wang S, et al. Among authors: chan kw.
Nat Commun. 2024 May 21;15(1):4301. doi: 10.1038/s41467-024-48514-8.
Nat Commun. 2024.
PMID: 38773089
Free PMC article.